Capital Fund Management S.A. Blueprint Medicines Corp Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

A detailed history of Capital Fund Management S.A. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Capital Fund Management S.A. holds 71,422 shares of BPMC stock, worth $6.44 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

71,422

Previous 53,236 34.16%

Holding current value

$6.44 Million

Previous $5.74 Million 15.09%

% of portfolio

0.02%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$84.1 - $120.5 $1.53 Million - $2.19 Million	18,186 Added 34.16%	71,422 $6.6 Million
Q2 2024 Aug 13, 2024	BUY	$85.18 - $108.78 $4.53 Million - $5.79 Million	53,236 New	53,236 $5.74 Million
Q2 2023 Aug 14, 2023	SELL	$42.2 - $66.37 $4.17 Million - $6.56 Million	-98,775 Reduced 78.62%	26,860 $1.7 Million
Q1 2023 May 15, 2023	SELL	$37.97 - $50.0 $2 Million - $2.63 Million	-52,659 Reduced 29.53%	125,635 $5.65 Million
Q4 2022 Feb 13, 2023	BUY	$41.06 - $66.48 $3.1 Million - $5.02 Million	75,534 Added 73.51%	178,294 $7.81 Million
Q3 2022 Nov 14, 2022	BUY	$49.93 - $77.7 $2.09 Million - $3.26 Million	41,954 Added 69.0%	102,760 $6.77 Billion
Q2 2022 Aug 12, 2022	BUY	$45.23 - $70.15 $787,861 - $1.22 Million	17,419 Added 40.15%	60,806 $3.07 Million
Q1 2022 May 12, 2022	BUY	$54.1 - $110.08 $2.35 Million - $4.78 Million	43,387 New	43,387 $2.77 Million
Q1 2020 May 13, 2020	SELL	$48.11 - $82.22 $282,742 - $483,206	-5,877 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$66.73 - $82.59 $392,172 - $485,381	5,877 New	5,877 $471,000
Q3 2018 Nov 14, 2018	SELL	$58.91 - $78.32 $2.5 Million - $3.32 Million	-42,400 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$60.96 - $101.18 $2.58 Million - $4.29 Million	42,400 New	42,400 $2.69 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.38B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account

Capital Fund Management S.A. Blueprint Medicines Corp Transaction History